KardiaPro vs Cardiomo

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Cardiomo, Inc.

AI Verdict

KardiaPro and Cardiomo are direct competitors, both offering AI-powered platforms for remote cardiac monitoring and arrhythmia detection. While KardiaPro focuses on integrating with its suite of Kardia devices for comprehensive data management and physician review, Cardiomo provides its own medical-grade wearable patch for continuous vital sign monitoring and real-time alerts to users and caregivers.

Choose KardiaPro if…

Choose KardiaPro if your healthcare practice requires a comprehensive, web-based portal for managing and reviewing remote patient ECG, blood pressure, and weight data. It is ideal for clinicians who need FDA-cleared AI for arrhythmia detection, customizable inboxes for efficient data review, and automated summary reports to analyze trends and make informed clinical decisions for a large patient population.

View KardiaPro →

Choose Cardiomo if…

Choose Cardiomo if you prioritize a medical-grade wearable device for continuous, real-time heart health monitoring, particularly for detecting cardiovascular diseases and providing immediate alerts to users and caregivers. This tool is best suited for scenarios where continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature) and fall detection are critical, offering peace of mind for patients and their families.

View Cardiomo →

When choosing between KardiaPro and Cardiomo, physicians should consider their primary need for data management versus continuous, real-time monitoring. KardiaPro, from AliveCor, offers a comprehensive web-based portal designed for efficient remote monitoring and management of patient ECG, blood pressure, and weight data. Its FDA-cleared AI focuses on arrhythmia detection and other cardiac determinations, making it ideal for practices that require a robust platform to review and analyze trends from various data sources between appointments. KardiaPro is best suited for physicians who prioritize a centralized system for managing intermittent patient-generated health data and integrating with existing KardiaMobile devices.

In contrast, Cardiomo provides a medical-grade wearable device paired with an AI-powered platform for continuous heart health monitoring. Its key practical difference lies in its emphasis on real-time, continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature) and immediate alerts for cardiovascular events. This makes Cardiomo more appropriate for physicians whose patients require constant oversight and prompt notification of potential issues, such as those with higher risk factors or those needing close post-discharge monitoring. Physicians needing a solution for proactive, continuous patient surveillance and immediate alerts would likely find Cardiomo more aligned with their practice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature KardiaPro Cardiomo
Pricing Contact for pricing Contact for pricing
Deployment Cloud-hosted, Web-based Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

KardiaPro

KardiaPro offers a comprehensive web-based portal with a customizable ECG inbox, automated summary reports, and trend visualization, suggesting a strong focus on healthcare professional workflow and ease of data review. Cardiomo, while offering a mobile app and real-time alerts, has limited public information regarding its professional-facing portal's usability and user reviews for ease-of-use are not available.

Clinical Value

KardiaPro

KardiaPro leverages FDA-cleared AI for arrhythmia detection and is integrated with KardiaMobile devices, which are described as the 'most clinically validated personal ECGs in the world' with over 200 clinical publications. Cardiomo also uses AI for disease detection and is a medical-grade wearable, but the extent of its clinical validation and published studies is less extensively documented in the provided information.

Pricing & Value

Tie

Both tools require contacting the company for current pricing, making a direct comparison of cost-effectiveness difficult. While Cardiomo previously offered a device with a monthly subscription, current details are not publicly available. KardiaPro mentions reimbursability using existing CPT codes, which could offer value to healthcare providers.

Enterprise Readiness

KardiaPro

KardiaPro is designed as a comprehensive web-based portal for remote monitoring, offering features like customizable ECG inboxes, automated reports, and integration with KardiaStation for point-of-care solutions, indicating a robust platform for enterprise use. It also highlights HIPAA compliance and SOC-2 certification. Cardiomo focuses on a wearable device and mobile app, with less emphasis on enterprise-level features like extensive portal customization or integration capabilities beyond its own cloud analytics.

Innovation

KardiaPro

KardiaPro's integration with FDA-cleared AI for arrhythmia detection and its continuous development of advanced personal ECG devices like KardiaMobile 6L (the first 6-lead personal ECG) demonstrates a strong commitment to innovation in cardiac monitoring. Cardiomo also utilizes AI for disease detection and offers continuous vital sign monitoring, but KardiaPro's established track record with multiple FDA clearances and extensive clinical validation gives it an edge in demonstrated innovation.

Support & Docs

KardiaPro

KardiaPro provides readily accessible user guides, FAQs, and direct contact information for support via phone and email on its website. Cardiomo's public information on support and documentation is less comprehensive, with limited details available beyond general contact information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature KardiaPro Cardiomo
Name KardiaPro Cardiomo
Company AliveCor Cardiomo, Inc.
Monitored Data Types ECG, blood pressure, and weight data ECG, heart rate, respiration, skin temperature
AI Capabilities FDA-cleared AI for arrhythmia detection and other cardiac determinations AI engine to detect cardiovascular diseases and provide life-saving alerts
Key Features Comprehensive web-based portal for remote monitoring, ECG, blood pressure, and weight data management, FDA-cleared AI for arrhythmia detection, Customizable ECG inbox for efficient data review, Automated summary reports and trend visualization, Seamless integration with KardiaMobile and KardiaMobile 6L devices, Integration with KardiaStation for point-of-care solutions, HIPAA-compliant and SOC-2 certified data handling Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology, Geriatrics, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring KardiaPro and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

KardiaPro offers EHR integration, SDK, and API offerings to automatically pull ECGs and patient data into your EHR system, simplifying workflow and enabling access to medical-grade heart data within existing workflows. Cardiomo's cloud-based platform is HIPAA-compliant and designed to provide real-time data and alerts to clinicians, but specific details on its EHR integration capabilities beyond general cloud analytics are not explicitly stated.
KardiaPro's FDA-cleared AI for arrhythmia detection has demonstrated high accuracy. For example, the KardiaMobile AF algorithm showed 96.6% sensitivity and 94% specificity compared to a cardiology over-read of 12-lead EKGs for AFib diagnosis. Cardiomo's proprietary algorithms are trained to detect arrhythmias and other cardiac events, analyzing biosensor data to spot abnormalities and provide timely alerts.
KardiaPro is designed with an intuitive web-based portal and a customizable ECG inbox for efficient data review, suggesting a manageable learning curve for healthcare professionals. While Cardiomo aims to be an 'easy solution' for monitoring heart health, specific details on the learning curve for physicians are not provided.
KardiaPro is SOC-2 certified and also holds ISO 27001 certification, indicating a high standard of data security and compliance beyond HIPAA. Cardiomo states its cloud analytics are HIPAA-compliant, but further certifications or specific security measures beyond HIPAA are not detailed in the provided information.
KardiaPro's SOC-2 certification implies robust internal controls, which typically include audit trails for data access and changes. While not explicitly detailed for Cardiomo, strong audit trails are a key feature for HIPAA compliance and cardiology information systems.
KardiaPro's EHR integration capabilities, including its availability on Epic's App Orchard Marketplace, suggest it is designed to support broader deployments within health systems by integrating into existing workflows. Cardiomo's cloud-based platform and real-time alert system could facilitate multi-site use, but specific features for large-scale deployment management are not outlined.
KardiaPro's FDA-cleared AI provides specific arrhythmia detections and automated summary reports with trend visualization to help physicians make informed clinical decisions. Cardiomo's AI-powered platform is designed to detect cardiovascular diseases and provide timely alerts, which can aid in identifying potential cardiac events and informing care.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.